Skip to search Skip to main content

Govt building Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure accsess Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

NLM Digital Collections
    • About
    • Help
    • Web Service

    « Previous Next »
    A-Z Sort Numerical Sort

    Titles

    1. All
    2. A
    3. B
    4. C
    5. D
    6. E
    7. F
    8. G
    9. H
    10. I
    11. J
    12. K
    13. L
    14. M
    15. N
    16. O
    17. P
    18. Q
    19. R
    20. S
    21. T
    22. U
    23. V
    24. W
    25. X
    26. Y
    27. Z
    • ACOs' strategies for transitioning to value-based care: lessons from the Medicare shared savings program1
    • ANDA submissions--amendments to abbreviated new drug applications under GDUFA1
    • ANDA submissions: amendments and requests for final approval to tentatively approved ANDAs1
    • ANDAs for certain highly purified synthetic peptide drug products that refer to listed drugs of rDNA origin1
    • Abuse and neglect: CMS should strengthen reporting requirements to better protect individuals receiving hospice care : report to the Honorable Charles E. Grassley, United States Senate1
    • Acceptance and filing reviews for premarket approval applications (PMAs): guidance for industry and Food and Drug Administration staff1
    • Access and use of electronic health information by individuals with cancer: 2017-20181
    • Access to Medicare Part D plans: a comparison of metropolitan and nonmetropolitan areas1
    • Access to preventive services without cost-sharing: evidence from the Affordable Care Act1
    • Achieving behavioral health care integration in rural America1
    • Acne vulgaris: establishing effectiveness of drugs intended for treatment1
    • Action level for inorganic arsenic in apple juice: guidance for industry1
    • Acute myeloid leukemia: developing drugs and biological products for treatment : guidance for industry1
    • Adaptive designs for clinical trials of drugs and biologics1
    • Addressing social determinants of health: examples of successful evidence-based strategies and current federal efforts1
    • Addressing the direct care workforce shortage: a bipartisan call to action1
    • Adjusting for covariates in randomized clinical trials for drugs and biological products: guidance for industry1
    • Administrative procedures for CLIA categorization: guidance for industry and Food and Drug Administration staff1
    • Adolescent and young adult substance use: federal grants for prevention, treatment, and recovery services and for research : report to Congressional committees1
    • Advance care planning among Medicare fee-for-service beneficiaries and practitioners: final report1
    « Previous Next »
    A-Z Sort Numerical Sort

    Connect with NLM

    • Facebook
    • LinkedIn
    • Twitter
    • You Tube

    National Library of Medicine
    8600 Rockville Pike
    Bethesda, MD 20894

    Web Policies
    FOIA
    HHS Vulnerability Disclosure

    NLM Support Center
    Accessibility
    Careers

    NLM | NIH | HHS | USA.gov